Introduction/Background The aim of this study was to compare the oncologic outcomes in stage I borderline ovarian tumors (BOTs) patients treated with unilateral ovarian cystectomy (UOC) versus unilateral salpingo-oophorectomy (USO).
Methodology This was a retrospective study of 95 patients with stage I BOTs treated with cystectomy (n=22) or unilateral salpingo-oophorectomy (n=73) between 2000 and 2017 at Keimyung University Dongsan Medical Center. The surgical and oncologic outcomes between the two groups (UOC versus USO) were compared.
Results After a median follow-up of 76 months (range: 10–215), there were 9 patients who had recurrences (UOC group: 4 vs. USO group: 5). The recurrence rate was higher in UOC group (18.2%) than in the USO group (6.8%).
However, there was no statistically significant difference in recurrence rates (p=0.104) and 5-year progression free-survival (p=0.099) between the two groups. All recurred patients except 1 patient (USO group) were successfully treated by secondary operation and were alive with no clinical evidence of disease. Only 1 patient was died due to disease.
Conclusion Our results support that both surgical methods are an acceptable treatment for women with stage I BOTs. Although USO is an appropriate treatment for BOTs patients, a UOC can be considered for patients who wish to preserve fertility when a unilateral cystectomy is the only surgical method.
Disclosure Nothing to disclose.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.